These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27114092)

  • 21. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.
    Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I
    Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
    Sidebottom AJ; May JE; Madahar AK
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease.
    Guidubaldi A; Fasano A; Ialongo T; Piano C; Pompili M; Mascianà R; Siciliani L; Sabatelli M; Bentivoglio AR
    Mov Disord; 2011 Feb; 26(2):313-9. PubMed ID: 21259343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ; Dahl JP; Rose AS
    Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1387-92. PubMed ID: 24974144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands.
    Taib BG; Williams SP; Sood S; Ung K; Nixon PP; Sharma R
    Br J Oral Maxillofac Surg; 2019 Jun; 57(5):442-448. PubMed ID: 31010597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review.
    Oliveira AF; Silva GA; Almeida DM
    Einstein (Sao Paulo); 2016; 14(3):431-434. PubMed ID: 27759834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
    Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
    J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.
    Barbero P; Busso M; Tinivella M; Artusi CA; De Mercanti S; Cucci A; Veltri A; Avagnina P; Calvo A; Chio' A; Durelli L; Clerico M
    J Neurol; 2015 Dec; 262(12):2662-7. PubMed ID: 26410746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound-guided botulinum toxin injections for treatment of drooling.
    Breheret R; Bizon A; Jeufroy C; Laccourreye L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):224-9. PubMed ID: 21600865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
    Chan KH; Liang C; Wilson P; Higgins D; Allen GC
    JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration.
    Pena AH; Cahill AM; Gonzalez L; Baskin KM; Kim H; Towbin RB
    J Vasc Interv Radiol; 2009 Mar; 20(3):368-73. PubMed ID: 19157908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
    Ondo WG; Hunter C; Moore W
    Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated treatments of drooling with botulinum toxin B in neurology.
    Møller E; Daugaard D; Holm O; Winge K; Bardow A; Lykkeaa J; Belhage B; Bakke M
    Acta Neurol Scand; 2015 Jan; 131(1):51-7. PubMed ID: 25270197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound-guided injection of botulinum toxin A into the submandibular gland in children and young adults with sialorrhoea.
    Gok G; Cox N; Bajwa J; Christodoulou D; Moody A; Howlett DC
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):231-3. PubMed ID: 22939893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onabotulinum Toxin A Injections Into the Salivary Glands for Spinal Muscle Atrophy Type I: A Prospective Case Series of 4 Patients.
    Shoval HA; Antelis E; Hillman A; Wei X; Tan P; Alejandro R; Kim H
    Am J Phys Med Rehabil; 2018 Dec; 97(12):873-878. PubMed ID: 30439739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands.
    Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C; Beuche W
    Laryngoscope; 2002 Jan; 112(1):82-6. PubMed ID: 11802043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.
    Bushara KO
    Med Hypotheses; 1997 Apr; 48(4):337-9. PubMed ID: 9160288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience.
    Martínez-Poles J; Nedkova-Hristova V; Escribano-Paredes JB; García-Madrona S; Natera-Villalba E; Estévez-Fraga C; López-Sendón Moreno JL; Avilés-Olmos I; Sánchez Díaz G; Martínez Castrillo JC; Alonso-Canovas A
    Toxins (Basel); 2018 May; 10(6):. PubMed ID: 29843420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.